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Mouse  thymus,  thymus-derived  lymphocytes,  and  brain  share  an  antigen 
determined by gene at the Thy-1 locus in chromosome 9 (1).  Two alleles have 
been identified  at  this  locus:  Thy-1 a,  coding for antigen  Thy-l.1  (or  0-AKR) 
present in AKR and seven other strains; and Thy-1 b, coding for antigen Thy-l.2 
(or 0-C3H) and present in C3H and all the remaining inbred strains. Injection of 
AKR  thymocytes into  inbred  mice  carrying  the  Thy-1 b allele  results  in  an 
immune response that can be measured either serologically by determining the 
level of antibodies in the recipients'  serum  (1) or by counting plaque-forming 
cells (PFC) detectable in spleens of the recipients by means of an assay, with 
AKR thymocytes as target cells (2). The magnitude of PFC and serum antibody 
responses after a single thymocyte injection depends on the genetic make-up of 
the recipient. Three genes controlling the PFC response to the Thy-l.1 antigen 
have been identified: Ir-Thy-lA and Ir-Thy-lB, which are closely linked to the 
major histocompatibility complex (H-2) of the mouse (3-6),  and Ir-5,  which is 
located at a distance of 17 cm to the right of the H-2 complex on chromosome 17 
(6). Previous genetic mapping with H-2 recombinant strains has indicated that 
the two Ir-Thy-1  loci are  located to the left of the IC subregion  (7).  Further 
experiments strongly suggested that either one or both Ir-Thy-1 loci map to the 
K rather than the I region of the H-2 complex (8). In this report, the study of an 
H-2  mutant,  CBA-H-2  ka  (M523)  (9),  and  its  parental  strain,  CBA/LacStoY 
(CBA) provided further evidence that one of these loci apparently resides in the 
K  region and might even be identical with the H-2K locus in that region. 
Materials  and Methods 
The response of the mice to the Thy-1.1 antigen was measured as follows: mice of both sexes at 
an age of 8-10 wk were injected intravenously with 4 × 107 AKR thymocytes. 6 days later, the mice 
were killed and their spleens tested for the number of PFC capable of lysing AKR thymocytes. The 
PFC assay was described in detail previously (2).  Briefly, spleen cells of immunized mice were 
mixed with AKR thymocytes and suspended in 0.7%  Bacte-agar (Difco Laboratories, Detroit, 
Mich.) containing 0.5 mg/ml DEAE-dextran (Pharmacia Fine Chemicals Ltd., Uppsala, Sweden). 
The mixture was spread on microscope slides which, thereafter, were incubated for 60 min at 37°C 
and 5% CO2 atmosphere. The slides were then covered with diluted (1:10) rabbit serum as a source 
of complement (C) and incubated for another 60 min. After incubation, slides were air dried, fixed 
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TABLE  I 
Numbers of PFC (Arithmetic Mean  +- SE) in Spleens of H-2 
Mutant and Parental Strains as well as Some of Their F~ 
Hybrids Immunized i.v. with 4  × 107 AKR Thymocytes 
Strain  H-2 haplotypes  No. of  animals  PFC/spleen 
CBA/LacStoY  k/k  24  10,254  -+  1,144 
(CBA ×  C57BL/6)F~  k/b  12  2,167  -+  296 
(CBA ×  DBA/2)FI  kid.  6  2,300  _+  291 
M523  ka]ka  18  506  _+  87 
(M523  x  C57BL/6)F~  ka/b  27  178  -+  37 
(M523  x  DBA/2)F~  ka/d  8  125  -+  45 
with 95% ethanol, rinsed with distilled water, and again air dried. Plaques from each spleen were 
scored on duplicate slides and the response expressed as the number of PFC per spleen. The 
specificity of the assay for Thy-1 antigens has been repeatedly demonstrated in previous studies 
(4-6). 
Selected anti-Ia sera were used to test the absorbing potency of the parental and mutant cells. 
Spleen cells were washed twice in phosphate-buffered  saline, and once in saline and then mixed 
with antiserum (one part packed cells and one part antiserum). The mixture was incubated for 30 
min at room temperature and another 30 rain at 37°C. The absorption was then repeated with fresh 
cells. 
Unabsorbed and absorbed sera were tested by means of a  microcytotoxicity assay with a  3:1 
mixture of normal guinea pig and rabbit sera as a source of C (10). The titer was expressed as the 
last dilution at which above-background killing was observed. 
Results 
Table I shows the results of an experiment in which response to the Thy-1.1 
antigen of the mutant strain was compared with that of the original strain.  As 
expected,  the  CBA strain  typed as a  high  responder since it carries the high 
responder haplotype H-2  k, whereas, the M523 mutant was a low responder. The 
difference in the responsiveness of the two strains was highly significant  (P < 
0.005) indicating that the H-2 mutation changed the responsiveness of the CBA 
strain from high to low. Furthermore,  significant differences were found when 
responsiveness of the FI hybrids of CBA strain was compared with responsive- 
ness of the corresponding FI hybrids ofM523 strain. Thus, (C57BL/6J × CBA)F1 
and  (DBA/2J  ×  CBA)F~  hybrids produced  more  than  2,000  PFC  per  spleen, 
whereas, (C57BL/6J × M523)F1 and (DBA/2J x M523)F1 under the same circum- 
stances produced fewer than 200 PFC per spleen. 
As can be seen in Table II, whenever the parental strain,  CBA, absorbed out 
an  Ia  antibody,  the  mutant  strains  also did  so.  These  data  indicate  that  Ia 
antigens of the CBA mice have not been changed by the H-2  ka mutation. 
Discussion 
Previous tests with M523 mice indicated that the gene affected by the muta- 
tion resides within the K  region of the H-2  complex (9,  11).  No evidence for a 
change  of any  gene  outside  the  complex  or  outside  the K  region  could  be 
obtained. The fact that the mutation altered the serologically detectable H-2K  k 
antigens  (cross-immunization  of M523 and  CBA results  in antibodies against 
antigens which co-cap with H-2.23, the private antigen of H-2Kk), indicates that 
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TABLE  II 
Absorption of Anti-la Sera by Spleen Cells of Mutant and 
Original Strains 
Antibodies 
Antiserum  Absorbed by  present 
Cytotoxic titer with cells 
CBA  M523 
(B10.HTT ×  A.SW)F~  anti-A,TL  Ia.l,2 
A.TH anti-A.TL  Ia.1,2,3 
B10.D2(R106)  anti-B10.A(5R)  Ia.7 
-  512  512 
B6  256  256 
CBA  0  0 
M523  0  0 
-  256  256 
B6  128  128 
CBA  0  0 
M523  0  0 
-  256  128 
CBA  0  0 
M523  0  0 
The finding that in all H-2 mutations thus far detected,  mixed lymphocyte 
reaction (MLR) occurs between cells of the original and the mutant strains (for a 
review and references,  see 13) has been interpreted by some as an indication 
that the I region must also have been affected by each mutation, since antigens 
controlled by the I region are known to cause strong MLR (14, 15). However, we 
have recently mapped the MLR-stimulating antigens of the H-2 mutants in the 
K  region and were unable to find any evidence that the I  region antigens had 
been affected by these mutations  (11).  A thorough serological analysis of anti- 
gens controlled by the I  region (Ia antigens) also failed to reveal any difference 
between the original and the mutant strains.  Some of these data are shown in 
Table II, while other data were reported elsewhere (12). 
All the studies performed thus far indicate that the M523 mutation occurred 
in the H-2K locus and there  is no reason  to suspect that  a  second mutation 
occurred outside the H-2K locus.  How, then,  does one reconcile these results 
with the finding reported here that the mutation altered the immune response 
to the Thy-1.1 antigen,  a trait expected to be controlled by the I region-like H- 
2-associated immune  responses to  other  antigens  (16,  17)? Three  alternative 
explanations are possible. 
The first possibility is that M523 is, in fact, a double mutant, one occurring in 
the H-2K locus of the K  region,  and the other in the Ir-Thy-1  locus of the I 
region.  We consider this explanation unlikely for the following reasons.  First, 
no change could be found in the two other phenotypic expressions of the I region 
(the  MLR antigens  and  the  Ia  antigens)  in the  mutant  strains.  Second,  the 
likelihood of two mutations occurring at two closely linked loci (H-2K and Ir) in 
the  several  thousand  mice tested  is very small.  Third,  and  most  important, 
mapping studies with H-2 recombinant strains indicate that one of the Ir-Thy-1 
loci  does indeed  map  in  the K  region  (8).  In  this  context,  it  should  also be 
mentioned that the Ir gene(s) controlling cell-mediated lympholysis of trinitro- 
phenyl-modified autologous cells has been recently mapped to the K  region (18). 
The second possibility is that two mutations occurred in the K  region of the 
CBA strain, one in the H-2K locus and the other in the Ir-Thy-1 locus. The latter 
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the H-2K locus. This possibility could only be proven by finding a recombinant 
separating the H-2K and Ir-Thy-1  loci.  However, we consider this possibility 
unlikely because of the probability argument mentioned above. 
The third possibility is that one of the Ir-Thy-1 loci is identical with the H-2K 
locus. This explanation is the most appealing to us since it best fits all the facts 
known about the H-2 mutations. However, more direct evidence will be neces- 
sary to prove that this third possibility is the correct explanation for our finding. 
Should it be, indeed, possible to demonstrate that the H-2K locus itself is one 
of the Ir loci, several interesting implications would follow. For one thing,  a 
hypothesis that the Ir  genes code for the T-cell receptor (16) would be a  less 
likely possibility. [Why, for instance, would a T-cell receptor be present on all 
tissues as are the H-2 antigens (17)?] Furthermore, it would be also necessary to 
conclude that  responsiveness to different classes of antigens is  controlled by 
different classes of the  major histocompatibility complex-linked Ir  loc~. And, 
finally, if it could be demonstrated thatIr-Thy-1 equals H-2K, the relatedness of 
the  different classes  of regions within the H-2  complex would be  even more 
underscored. The latter view has been propounded by one of us (J. K.) for some 
time. 
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